Cargando…
COVID-19: Postmortem Diagnostic and Biosafety Considerations
As a result of the 2019 novel human coronavirus (COVID-19) global spread, medical examiner/coroner offices will inevitably encounter increased numbers of COVID-19–infected decedents at autopsy. While in some cases a history of fever and/or respiratory distress (eg, cough or shortness of breath) may...
Autores principales: | Lacy, J. Matthew, Brooks, Erin G., Akers, Joshua, Armstrong, Danielle, Decker, Lauren, Gonzalez, Adam, Humphrey, William, Mayer, Romana, Miller, Matthew, Perez, Catherine, Arango, Jose Antonio Ruiz, Sathyavagiswaran, Lakshmanan, Stroh, Wendy, Utley, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202125/ https://www.ncbi.nlm.nih.gov/pubmed/32379077 http://dx.doi.org/10.1097/PAF.0000000000000567 |
Ejemplares similares
-
Current Biosafety Considerations in Stem
Cell Therapy
por: Mousavinejad, Masoumeh, et al.
Publicado: (2016) -
Immunological considerations for laboratory staff and COVID-19 biosafety
por: Kintossou, Ambroise Kouame, et al.
Publicado: (2023) -
Biosafety Considerations of Mammalian-Transmissible H5N1 Influenza
por: Imperiale, Michael J., et al.
Publicado: (2012) -
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
por: Baldo, Aline, et al.
Publicado: (2015) -
Optimization of stimulation parameters for epi-retinal implant based on biosafety consideration
por: Lu, Yijie, et al.
Publicado: (2020)